Intra-Cellular Therapies Statistics
Total Valuation
ETR:3RB has a market cap or net worth of EUR 43.40 billion. The enterprise value is 53.12 billion.
Market Cap | 43.40B |
Enterprise Value | 53.12B |
Important Dates
The last earnings date was Thursday, July 24, 2025.
Earnings Date | Jul 24, 2025 |
Ex-Dividend Date | Apr 10, 2025 |
Share Statistics
Current Share Class | 679.10M |
Shares Outstanding | n/a |
Shares Change (YoY) | -3.69% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 672.40M |
Valuation Ratios
The trailing PE ratio is 29.95 and the forward PE ratio is 15.61.
PE Ratio | 29.95 |
Forward PE | 15.61 |
PS Ratio | 2.66 |
PB Ratio | 5.86 |
P/TBV Ratio | n/a |
P/FCF Ratio | 17.63 |
P/OCF Ratio | 14.81 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.69, with an EV/FCF ratio of 21.58.
EV / Earnings | 36.66 |
EV / Sales | 3.31 |
EV / EBITDA | 12.69 |
EV / EBIT | 14.16 |
EV / FCF | 21.58 |
Financial Position
The company has a current ratio of 0.56, with a Debt / Equity ratio of 1.48.
Current Ratio | 0.56 |
Quick Ratio | 0.36 |
Debt / Equity | 1.48 |
Debt / EBITDA | 2.58 |
Debt / FCF | 4.46 |
Interest Coverage | 8.03 |
Financial Efficiency
Return on equity (ROE) is 17.37% and return on invested capital (ROIC) is 12.40%.
Return on Equity (ROE) | 17.37% |
Return on Assets (ROA) | 8.01% |
Return on Invested Capital (ROIC) | 12.40% |
Return on Capital Employed (ROCE) | 20.61% |
Revenue Per Employee | 430,410 |
Profits Per Employee | 38,230 |
Employee Count | 37,900 |
Asset Turnover | 0.55 |
Inventory Turnover | 3.42 |
Taxes
In the past 12 months, ETR:3RB has paid 753.62 million in taxes.
Income Tax | 753.62M |
Effective Tax Rate | 34.00% |
Stock Price Statistics
The stock price has increased by +27.99% in the last 52 weeks. The beta is 0.10, so ETR:3RB's price volatility has been lower than the market average.
Beta (5Y) | 0.10 |
52-Week Price Change | +27.99% |
50-Day Moving Average | 59.82 |
200-Day Moving Average | 59.52 |
Relative Strength Index (RSI) | 67.07 |
Average Volume (20 Days) | 9,021 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ETR:3RB had revenue of EUR 16.31 billion and earned 1.45 billion in profits. Earnings per share was 2.10.
Revenue | 16.31B |
Gross Profit | 9.93B |
Operating Income | 3.81B |
Pretax Income | 2.22B |
Net Income | 1.45B |
EBITDA | 4.16B |
EBIT | 3.81B |
Earnings Per Share (EPS) | 2.10 |
Balance Sheet
The company has 1.12 billion in cash and 10.97 billion in debt, giving a net cash position of -9.84 billion.
Cash & Cash Equivalents | 1.12B |
Total Debt | 10.97B |
Net Cash | -9.84B |
Net Cash Per Share | n/a |
Equity (Book Value) | 7.41B |
Book Value Per Share | 10.84 |
Working Capital | -4.53B |
Cash Flow
In the last 12 months, operating cash flow was 2.93 billion and capital expenditures -468.97 million, giving a free cash flow of 2.46 billion.
Operating Cash Flow | 2.93B |
Capital Expenditures | -468.97M |
Free Cash Flow | 2.46B |
FCF Per Share | n/a |
Margins
Gross margin is 60.89%, with operating and profit margins of 23.38% and 8.88%.
Gross Margin | 60.89% |
Operating Margin | 23.38% |
Pretax Margin | 13.59% |
Profit Margin | 8.88% |
EBITDA Margin | 25.49% |
EBIT Margin | 23.38% |
FCF Margin | 15.09% |
Dividends & Yields
This stock pays an annual dividend of 2.36, which amounts to a dividend yield of 3.69%.
Dividend Per Share | 2.36 |
Dividend Yield | 3.69% |
Dividend Growth (YoY) | 5.29% |
Years of Dividend Growth | 8 |
Payout Ratio | 112.41% |
Buyback Yield | 3.69% |
Shareholder Yield | 7.31% |
Earnings Yield | 3.34% |
FCF Yield | 5.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
ETR:3RB has an Altman Z-Score of 3.16 and a Piotroski F-Score of 7.
Altman Z-Score | 3.16 |
Piotroski F-Score | 7 |